Dr Russell G Greig, President and Founder of Greig Biotechnology Global Consulting, Inc.
Dr. Greig served nearly three decades with pharmaceutical giant GlaxoSmithKline, most recently as President of SR One, GSK’s Corporate Venture Group following a term as President of GSK's Pharmaceuticals International. Following the merger of SmithKline Beecham with Glaxo Wellcome in 2000, Dr. Greig served as Senior Vice President for Worldwide Business Development. Prior to that, Dr. Greig was Managing Director and General Manager of SmithKline Beecham's UK Pharmaceuticals, as well as Vice President and Director of European Market Development of SmithKline Beecham's European Pharmaceutical Operations. He also served as Vice President and Director of Advanced Technologies in Genetics. He holds a Ph.D. in biochemistry from the University of Manchester, England, and is a former Fulbright Scholar.